Monte Rosa Therapeutics, Inc. (GLUE)

18.80 -0.35 (-1.83%) USD  |  NASDAQ  |  May 01, 16:00
18.50 -0.30 (-1.60%) After-Hours: 20:00
More

Monte Rosa Therapeutics EPS Diluted (5 Year Growth)

EPS Diluted (5 Year Growth) Chart

View EPS Diluted (5 Year Growth) for GLUE.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted (5 Year Growth) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EPS Diluted (5 Year Growth) Range, Past 5 Years

View EPS Diluted (5 Year Growth) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (5 Year Growth) Benchmarks

View EPS Diluted (5 Year Growth) Benchmarks
Start Trial
Johnson & Johnson Upgrade
Agenus, Inc. Upgrade
BioRestorative Therapies, Inc. Upgrade
Kyntra Bio, Inc. Upgrade
Kura Oncology, Inc. Upgrade